If You Invested in Cloud DX Inc (CDXFF)
See the CDXFF overviewWhat $1,000 or $10,000 in CDXFF Was Worth at Its Last Close
Real historical value by amount invested and how long before the last close| If you invested | 1 year before | 5 years before | 10 years before | Since Jun 8, 2021 |
|---|---|---|---|---|
| $1,000 | $1,089 +9% | — | — | $207 -79% |
| $10,000 | $10,895 +9% | — | — | $2,065 -79% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2024-09-04. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for CDXFF$1,000 Investment Over Time
CDXFF vs S&P 500Year-by-Year Returns
CDXFF annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2021Jun 8 to Dec 31 | $0.4067 | $0.3568 | -12.3% | -12.3% |
| 2022 | $0.3568 | $0.1068 | -70.1% | -73.7% |
| 2023 | $0.1068 | $0.0703 | -34.2% | -82.7% |
| 2024Dec 29, 2023 to Sep 4 | $0.0703 | $0.0840 | +19.5% | -79.3% |
About Cloud DX Inc
OTC
Cloud DX Inc. (OTCQB: CDXFF), historically associated with the surgical and medical instrument manufacturing industry, operated as a digital health company focused on virtual care and remote patient monitoring. According to multiple company news releases, Cloud DX developed and deployed the Connected Health™ remote patient monitoring platform, which was used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home.
The company stated that its partners used Connected Health to help patients manage chronic conditions, reduce the need for hospitalization or re-admission, and lower healthcare delivery costs through more efficient use of resources. Cloud DX described itself as a North American provider of virtual care and remote patient monitoring platforms, with contracts and relationships that included hospitals, community paramedic services, clinics, and provincial or territorial health authorities.
Cloud DX highlighted that its Connected Health platform supported programs where community paramedics and other care teams could monitor seniors and other patients where they live, track vital signs and symptoms, and interact with patients through a mobile app. The company indicated that this approach was used to help people remain at home longer, manage chronic diseases, and support post-surgical recovery outside of hospital settings.
In its public communications, Cloud DX reported that it had secured multiple provincial-level contracts for remote patient monitoring services in Canada, as well as agreements with hospitals, academic medical centers, family health teams, community paramedic services, and clinics. It also referenced a Master Services Agreement with a shared services organization that manages procurement for hospital systems and provincial authorities. These disclosures positioned Cloud DX as a supplier of remote patient monitoring products and services to a range of institutional healthcare customers.
The company also emphasized recognition it had received, noting that Cloud DX was the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and identified as one of "Canada's Ten Most Prominent Telehealth Providers." In various releases, Cloud DX further noted that it had been named a "2022 Top Innovator" by Canadian Business.
Cloud DX’s public statements described an overarching mission of "accelerating digital healthcare" and a goal to make healthcare better for everyone. The Connected Health platform was presented as a way for healthcare organizations to deliver virtual care, manage complex patients remotely, and use resources more efficiently while aiming for improved patient and provider outcomes.
Corporate restructuring and cessation of operations
Subsequent disclosures show that Cloud DX underwent a significant restructuring process. On June 6, 2024, the company announced that its wholly owned subsidiary, Cloud Diagnostics Canada ULC, had filed a Notice of Intention to Make a Proposal under the Bankruptcy and Insolvency Act (Canada). Cloud Diagnostics Canada ULC was described as a material subsidiary that accounted for most of the company’s revenues. The NOI filing initiated a court-supervised process intended to allow a restructuring of the subsidiary’s affairs and to support a sale and investment solicitation process.
On December 16, 2024, Cloud DX reported the sale of its wholly owned subsidiary Cloud Diagnostics Canada ULC to 1493907 B.C. Ltd. under a reverse vesting order granted by the Supreme Court of British Columbia. As part of this transaction, existing shares in Cloud Diagnostics Canada ULC were cancelled, new shares were issued to the purchaser, and a new entity was incorporated and vested with certain excluded liabilities, with that new entity expected to be assigned into bankruptcy under the Bankruptcy and Insolvency Act.
On June 11, 2025, Cloud DX disclosed that it had received a Cease Trade Order from the Ontario Securities Commission on May 7, 2025, due to its inability to file audited financial statements for the 2024 fiscal year. The same release stated that trading of the company’s shares had initially been halted when a subsidiary filed the NOI in June 2024 and that, following completion of the reverse vesting transaction on December 13, 2024, the company ceased operations and all assets of the company were transferred to the purchaser. The news release further noted that on May 27, 2025, the company’s board of directors was dissolved.
Based on these public disclosures, Cloud DX Inc. is best understood in historical terms. The CDXFF symbol is associated with a company that formerly operated a remote patient monitoring and virtual care platform, but which reported that it had ceased operations and transferred its assets following a court-supervised transaction. Investors researching CDXFF should treat this as a former operating company with a restructuring and asset transfer history, rather than an ongoing growth-stage issuer.
Business focus before cessation of operations
Before the restructuring and cessation of operations, Cloud DX’s stated business focus centered on:
- Remote patient monitoring (RPM): Providing the Connected Health remote patient monitoring platform to healthcare enterprises and care teams across North America.
- Virtual care delivery: Enabling chronic disease management, aging in place, and post-surgical care at home through connected monitoring and communication tools.
- Institutional healthcare contracts: Supplying RPM products and services under contracts with hospitals, community paramedic services, clinics, and provincial or territorial health authorities, as described in the company’s news releases.
These activities framed Cloud DX as a digital health and remote monitoring provider within the broader manufacturing and medical technology ecosystem, with its stock traded on the TSX Venture Exchange under the symbol CDX and on the OTCQB under the symbol CDXFF during its operating period.
Frequently Asked Questions
Cloud DX Inc investment returns
How much was $1,000 invested in Cloud DX Inc worth at its last close?
If you invested $1,000 in Cloud DX Inc (CDXFF) 1 year before its last close, on 2023-09-05, your investment was worth $1,089 on 2024-09-04, a +8.9% price return without dividends, growing at a compounded rate of 9.0% per year (CAGR).
Has Cloud DX Inc outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare CDXFF performance over available time periods.
What is Cloud DX Inc's average annual return?
The compound annual growth rate (CAGR) of CDXFF’s share price over the 1 year to Sep 4, 2024 is 9.0%, without dividends. Individual years vary a great deal, and CDXFF’s best recent full year was 2023 (-34.2%) while the worst was 2022 (-70.1%).
For informational and educational purposes only, not investment advice.